A. Moreauaubry et al., IDENTIFICATION OF A GP100 EPITOPE RECOGNIZED BY HLA-A3 RESTRICTED MELANOMA INFILTRATING LYMPHOCYTES, International journal of oncology, 10(4), 1997, pp. 841-846
The large majority of known melanoma-associated antigenic peptides pre
sented by MHC class I molecules are presented by the most frequent all
ele, HLA-A0201. Thus although a significant percentage of Caucasians
express HLA-A3, no melanoma-associated antigenic peptide presented by
this allele has yet been identified. We show here that the T cell clon
e M45-10 isolated from tumor infiltrating lymphocytes recovered from a
melanoma biopsy recognizes the gp100-derived peptide ALLAVGATK presen
ted by HLA-A0301. Since gp100 is expressed on most melanoma cells, ou
r results imply that the gp100-based anti-melanoma strategies develope
d for individuals expressing HLA-A2 will also be applicable to those e
xpressing HLA-AS (about one Caucasian in four). gp100 is therefore a p
articularly promising melanoma antigen, as different peptides derived
from it can be presented by at least two different frequently encounte
red HLA class I molecules.